Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

May 21, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

October 28, 2019

Conditions
Enteric Hyperoxaluria
Interventions
DRUG

ALLN-177

ALLN-177 7,500 units (2 capsules), orally, with each meal/snack, 3 to 5 times per day for 28 days

DRUG

Placebo

Placebo 2 capsules, orally, with each meal/snack, 3 to 5 times per day for 28 days

Trial Locations (63)

10021

Park Avenue Endocrinology & Nutrition, New York

10032

Columbia University Medical Center, New York

10117

Charite Universitaetsmedizin Berlin, Berlin

10461

Albert Einstein College of Medicine Montefiore Medical Center, The Bronx

11803

Advanced Urology Centers of New York, Plainview

16132

IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova

17007

Hospital Universitari de Girona Doctor Josep Trueta, Girona

21076

Chesapeake Urology, Hanover

23235

Virginia Urology, Richmond

23462

Urology of Virginia, Virginia Beach

23800

ASST di Lecco, Lecco

23900

Azienda Socio-Sanitaria Territoriale di Lecco (ASST di Lecco), Lecco

24008

Complejo Asistencial de León, León

27599

University of North Carolina Chapel Hill, Chapel Hill

27612

Associated Urologists of North Carolina, Raleigh

27710

Duke University Medical Center, Durham

28040

Fundacion Jimenez Diaz, Madrid

28401

Coastal Urology, Wilmington

28702

Hospital Universitario Infanta Sofia, Madrid

32114

Advanced Urology Institute, Daytona Beach

32224

Mayo Clinic - Jacksonville, Jacksonville

32751

Center for Advanced GI (CFAGI), Maitland

33186

South Medical Research Group, Inc., Miami

35209

Urology Centers of Alabama, Birmingham

35294

University of Alabama, Department of Urology, Birmingham

37232

Vanderbilt University Medical Center, Nashville

41013

Hospital Universitario Virgen del Rocio, Seville

43606

Genito-Urinary Surgeons, Toledo

45212

Tristate Urologic Services PSI Inc, Cincinnati

46202

IU Health Physicians, Indianapolis

53113

Universitat Bonn - Zentrum für Kinderheilkunde, Bonn

53127

Universitaetsklinikum Bonn; Klinik und Poliklinik für Urologie und Kinderurologie, Bonn

54500

CHU de Nancy-Hopital Brabois, Vandœuvre-lès-Nancy

55128

PSHI GmbH; PFÜTZNER Science & Health Institute GmbH, Mainz

55905

Mayo Clinic-Dept. of Nephrology, Rochester

60607

Edmund J. Lewis and Associates, Chicago

63110

Washington University School of Medicine, St Louis

68114

The Urology Center, P.C., Omaha

71106

Regional Urology, Shreveport

72212

Applied Research Center of Arkansas, Little Rock

75246

Renal Disease Research Institute, Dallas

77027

Houston Metro Urology, Houston

77429

Houston Nephrology Group, Cypress

79106

Universitatsklinikum Freiburg, Klinik for Urologie, Freiburg im Breisgau

81377

Universitat Munchen - Großhadern, Munich

83642

Idaho Urologic Institue, Meridian

83814

North Idaho Urology, Coeur d'Alene

84132

University of Utah, Salt Lake City

85054

Mayo Clinic Hospital, Phoenix

85715

Urological Associates of Southern Arizona, Tucson

93301

TROVARE Clinical Research, Bakersfield

04102

Maine Nephrology Associates, Portland

04856

Pen Bay Medical Center, Rockport

02114

Massachusetts General Hospital, Boston

T6G1Z1

University of Alberta, Division of Urology, Edmonton

V8T2C1

Silverado Research Inc, Victoria

L4L 4YL

Toronto Digestive Disease Associates, Inc., Vaughan

H2X 0A9

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal

G1L 3L5

Research center of CHU de Québec - Université Laval (CHUL), Québec

04103

Universitaetsklinikum Leipzig, Leipzig

00168

Fondazione Policlinico Universitario A. Gemelli - Universita Cattolica del Sacro Cuore, Rome

NW3 2QG

The Royal Free Hospital, London

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Allena Pharmaceuticals

INDUSTRY

NCT03456830 - Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria | Biotech Hunter | Biotech Hunter